DK198785A - 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconatog farmaceutiske praeparater som indeholder dette stof - Google Patents

2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconatog farmaceutiske praeparater som indeholder dette stof Download PDF

Info

Publication number
DK198785A
DK198785A DK198785A DK198785A DK198785A DK 198785 A DK198785 A DK 198785A DK 198785 A DK198785 A DK 198785A DK 198785 A DK198785 A DK 198785A DK 198785 A DK198785 A DK 198785A
Authority
DK
Denmark
Prior art keywords
ethoxycarbonylamino
benzylamino
fluoro
amino
pyridine
Prior art date
Application number
DK198785A
Other languages
English (en)
Other versions
DK198785D0 (da
DK157016C (da
DK157016B (da
Inventor
Helmut Hettche
Peter Emig
Juergen Engel
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of DK198785D0 publication Critical patent/DK198785D0/da
Publication of DK198785A publication Critical patent/DK198785A/da
Publication of DK157016B publication Critical patent/DK157016B/da
Application granted granted Critical
Publication of DK157016C publication Critical patent/DK157016C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK198785A 1984-05-05 1985-05-02 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat, laegemidler indeholdende dette samt fremstilling af disse laegemidler DK157016C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3416609 1984-05-05
DE19843416609 DE3416609A1 (de) 1984-05-05 1984-05-05 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten

Publications (4)

Publication Number Publication Date
DK198785D0 DK198785D0 (da) 1985-05-02
DK198785A true DK198785A (da) 1985-11-06
DK157016B DK157016B (da) 1989-10-30
DK157016C DK157016C (da) 1990-03-26

Family

ID=6235001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198785A DK157016C (da) 1984-05-05 1985-05-02 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat, laegemidler indeholdende dette samt fremstilling af disse laegemidler

Country Status (25)

Country Link
US (1) US4673666A (da)
EP (1) EP0160865B1 (da)
JP (1) JPS60239469A (da)
KR (1) KR850008678A (da)
AT (1) ATE33638T1 (da)
AU (1) AU4194385A (da)
BG (1) BG44537A3 (da)
CA (1) CA1263398A (da)
CS (1) CS248743B2 (da)
DD (1) DD236927A5 (da)
DE (2) DE3416609A1 (da)
DK (1) DK157016C (da)
ES (1) ES542817A0 (da)
FI (1) FI80443C (da)
GR (1) GR851065B (da)
HU (1) HU193753B (da)
IE (1) IE57766B1 (da)
IL (1) IL75086A (da)
MC (1) MC1651A1 (da)
NO (1) NO851772L (da)
PL (1) PL253202A1 (da)
PT (1) PT80386B (da)
SU (1) SU1398772A3 (da)
YU (1) YU71785A (da)
ZA (1) ZA853351B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
DE102005054610B4 (de) * 2005-11-08 2010-06-10 Awd.Pharma Gmbh & Co. Kg Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
WO2009152142A1 (en) * 2008-06-09 2009-12-17 Awd. Pharma Gmbh & Co. Kg Sulfonate salts of flupirtine
WO2009152168A2 (en) 2008-06-09 2009-12-17 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102850265B (zh) * 2011-06-29 2015-11-25 陈小花 一种氟吡汀偶联物及其制备方法和用途
CN102351786A (zh) * 2011-11-01 2012-02-15 东南大学 一种氟吡汀丙二酸盐及其制备方法
CN103910674B (zh) * 2013-12-19 2015-12-02 天津红日药业股份有限公司 用于马来酸氟吡汀分析中的参比化合物
CN104974087A (zh) * 2015-01-30 2015-10-14 吉林修正药业新药开发有限公司 一种氟吡汀二聚体的合成方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133519A1 (de) * 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate

Also Published As

Publication number Publication date
HUT37758A (en) 1986-02-28
CS248743B2 (en) 1987-02-12
FI80443B (fi) 1990-02-28
PL253202A1 (en) 1986-07-15
CA1263398A (en) 1989-11-28
FI851752A0 (fi) 1985-05-03
FI80443C (fi) 1990-06-11
IE851117L (en) 1985-11-05
BG44537A3 (en) 1988-12-15
EP0160865B1 (de) 1988-04-20
FI851752L (fi) 1985-11-06
IE57766B1 (en) 1993-03-24
NO851772L (no) 1985-11-06
PT80386B (de) 1987-04-16
HU193753B (en) 1987-11-30
SU1398772A3 (ru) 1988-05-23
IL75086A0 (en) 1985-09-29
AU4194385A (en) 1985-11-07
DD236927A5 (de) 1986-06-25
ES8603423A1 (es) 1985-12-16
DE3416609A1 (de) 1985-11-07
US4673666A (en) 1987-06-16
PT80386A (de) 1985-06-01
GR851065B (da) 1985-11-25
JPH0144185B2 (da) 1989-09-26
ZA853351B (en) 1985-12-24
MC1651A1 (fr) 1986-04-07
DK198785D0 (da) 1985-05-02
ES542817A0 (es) 1985-12-16
DK157016C (da) 1990-03-26
DK157016B (da) 1989-10-30
YU71785A (en) 1988-02-29
KR850008678A (ko) 1985-12-21
DE3562242D1 (en) 1988-05-26
JPS60239469A (ja) 1985-11-28
EP0160865A3 (en) 1986-03-12
IL75086A (en) 1988-03-31
ATE33638T1 (de) 1988-05-15
EP0160865A2 (de) 1985-11-13

Similar Documents

Publication Publication Date Title
DK198785D0 (da) 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconatog farmaceutiske praeparater som indeholder dette stof
NO830110L (no) 6-substituert-s-triazolo(3,4-a)ftalazinderivater og fremgangsmaate for deres fremstilling
PT83872A (de) Arzneimittel
DK302885D0 (da) Anti-bakterielle forbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK163923C (da) 2-phenyl-3-aminomethyl-imidazooe1,2-aaapyridinderivater og farmaceutisk praeparat indeholdende saadanne forbindelser
NO157180C (no) Fremgangsmaate til fremstilling av vandige klebestoffblanding og anvendelse av den for maskinell etikettering, spesielt av glassvarer.
DK93685D0 (da) Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK156053C (da) S-(carbamoyl-phenylselenyl)-derivater af glutathion og af alfa-aminomercaptocarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
FI812811A7 (fi) N-oksasyklyyli-alkyylipiperidiinien N- oksideja, menetelmä niiden valmistamiseksi, näitä yhdisteitä sisältävifarmaseuttisia valmisteita ja niiden käyttö.
FI824531A7 (fi) N-oksidi-yhdisteet, menetelmä niiden valmistamiseksi ja näitä sisältävät farmaseuttiset valmisteet.
FI793375A7 (fi) Antikoagulantti, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset valmisteet.
DK612788A (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
NL192387B (nl) Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat.
RO87709A (ro) Procedeu pentru prepararea unor 1,1-alcandioli-carboxilati
FI860660A7 (fi) Menetelmä kaasuvirtojen sekoittumisen säätämiseksi.
FI853866A7 (fi) 2-pyridiini-tioli-johdannaiset, menetelmäniiden valmistamiseksi ja niitä sisältävät farmaseuttiset yhdisteet.
FI793552A7 (fi) 6-hydroksi-2,3-4-5-tetrahydro-1H-1- bentsatsepin-2-onin aminopropanolijohdannaiset, menetelmä niiden valmivalmistamiseksi ja niitä sisältävät farmaseuttiset valmisteet.
SE9004169D0 (sv) Anvaendning av farmaceutiska och kosmetiska kompositioner, innehaallande 1,8-dihydroxi-10-fenyl-9-antron som verksam bestaandsdel
FI853868A7 (fi) Pyridiinijohdannaiset, menetelmä niitten valmistamiseksi ja niitä sisältävät farmaseuttiset yhdisteet.
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
FI813693A7 (fi) Uudet 3-tiovinyyli-kefalosporiinit, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset vvalmisteet.
FI833443A0 (fi) 1,2,3,4-tetrahydro-1-aminometyl-4-fenylisokinoliner och foerfaranden foer framstaellning av dem
FI855017A7 (fi) Menetelmä 26,26,26-trifluor-1 ,25 -dihydroksikolekalsiferolin valmistamiseksi.
DK162227C (da) 3-aminopropoxyphenylderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater, som indeholder disse derivater
DE3577202D1 (de) Hexahydroindolizinverbindungen, pharmazeutische zubereitungen, methode und zwischenprodukte.

Legal Events

Date Code Title Description
PUP Patent expired